Cargando…
Effect of Iron Therapy on Platelet Counts in Patients with Inflammatory Bowel Disease-Associated Anemia
BACKGROUND AND AIMS: Secondary thrombocytosis is a clinical feature of unknown significance. In inflammatory bowel disease (IBD), thrombocytosis is considered a marker of active disease; however, iron deficiency itself may trigger platelet generation. In this study we tested the effect of iron thera...
Autores principales: | Kulnigg-Dabsch, Stefanie, Evstatiev, Rayko, Dejaco, Clemens, Gasche, Christoph |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3323537/ https://www.ncbi.nlm.nih.gov/pubmed/22506024 http://dx.doi.org/10.1371/journal.pone.0034520 |
Ejemplares similares
-
Clinical Significance of C-Reactive Protein Levels in Predicting Responsiveness to Iron Therapy in Patients with Inflammatory Bowel Disease and Iron Deficiency Anemia
por: Iqbal, Tariq, et al.
Publicado: (2014) -
Iron deficiency alters megakaryopoiesis and platelet phenotype independent of thrombopoietin
por: Evstatiev, Rayko, et al.
Publicado: (2014) -
Increased expression of HIF2α during iron deficiency–associated megakaryocytic differentiation
por: Jimenez, K., et al.
Publicado: (2015) -
Autoimmune gastritis
por: Kulnigg-Dabsch, Stefanie
Publicado: (2016) -
An Intracytoplasmic IL-10 Receptor Variant Permits Rapid Reduction in STAT3 Activation
por: Finsterbusch, Michaela, et al.
Publicado: (2011)